Article
Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor.
European journal of dermatology : EJD - 1 Oct 2021
Rubió-Casadevall Jordi, Carbó-Bagué Anna, Puigdemont Montserrat, Osca-Gelis Gemma, Oliveras Gloria, Vilar-Coromina Neus, Ferrer-Fabrega Berta, Urban Antoni, Llobet-Roma Montserrat, Martín-Romero Ferran, Perez-Bueno Ferran, Marcos-Gragera Rafael
Abstract excerpt
The prevalence of BRAF mutation has been reported in between 38% and 48% of melanoma patients, based on mainly Stage III or metastatic melanoma, however, information based on population-based studies is scarce. We performed a population-based retrospective cohort study to determine the prevalence of the BRAF mutation in patients diagnosed with in situ and infiltrating cutaneous malignant melanoma in the province...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.